Group items tagged

WASHINGTON — President-elect Joseph R. Biden Jr., racing against a surge in coronavirus cases and the emergence of a new variant that could significantly worsen the pandemic, is planning a vaccination offensive that calls for greatly expanding access to the vaccine while promising to use a wartime law to expand production.

The president-elect said he would invoke the Defense Production Act, if necessary, to build up vaccine supply.

The Biden team promised to ramp up vaccination in pharmacies, and build mobile vaccination clinics to get vaccine to hard-to-reach and underserved rural and urban communities, emphasizing equity in distribution.

Indonesia became the first country outside China to give emergency use approval to a Covid-19 vaccine developed by Chinese drugmaker Sinovac Biotech Ltd., despite findings that place the candidate’s efficacy among the lowest for new coronavirus vaccines

Indonesia’s food and drug agency said Monday that a late-stage clinical trial in the large city of Bandung showed Sinovac’s CoronaVac vaccine to be 65.3% effective. That compares to clinical trial results out of Brazil last week showing the vaccine had an efficacy rate of 78%.

A rate of 65% exceeds the 50% threshold that the World Health Organization and many regulatory authorities consider necessary for widespread use. Western vaccines developed by Moderna Inc. and jointly by Pfizer Inc. and BioNTech SE have reported their vaccines to be more than 90% effective; another developed by the University of Oxford and AstraZeneca PLC was at least 62% effective, according to the team.

South Korea appears to have cracked the code for managing the coronavirus. Its solution is straightforward, flexible and relatively easy to replicate.

The country has averaged about 77 new daily cases since early April and recently suppressed a spike in infections. Adjusting for population, that would be the equivalent of about 480 cases a day in the U.S., where new daily cases have averaged about 38,000 over the same period.

South Korea halted virus transmission better than any other wealthy country during the pandemic’s early months. It was about twice as effective as the U.S. and U.K. at preventing infected individuals from spreading the disease to other

Many scientists are reluctant to say with certainty that the vaccines prevent transmission of the virus from one person to another. This can be misinterpreted as an admission that the vaccines do not work. That’s not the case.

Why would scientists make vaccines that protect against only a disease rather than the virus that causes it? They don’t set out to do that, but it is the result, in part, of the exigencies of clinical trials. Practically, clinical trials can be completed more quickly if the endpoint of the trial — the main scientific question the trial is investigating — is something that can be easily observed. If SARS-CoV-2 infection were the trial endpoint, participants in the clinical trials would need to be tested at least weekly.

There are many vaccines that do not provide fully sterilizing immunity but nonetheless have huge public health benefits. Every year, the flu vaccine saves lives and keeps people out of the hospital despite the fact that it doesn’t prevent infection altogether.

Earlier this year, women became the majority of the workforce for the first time in U.S. history. Most managers are now women too. And for every two men who get a college degree this year, three women will do the same

Why wouldn’t you choose a girl? That such a statement should be so casually uttered by an old cowboy like Ericsson—or by anyone, for that matter—is monumental. For nearly as long as civilization has existed, patriarchy—enforced through the rights of the firstborn son—has been the organizing principle, with few exceptions

“You have to be concerned about the future of all women,” Roberta Steinbacher, a nun-turned-social-psychologist, said in a 1984 People profile of Ericsson. “There’s no question that there exists a universal preference for sons.”

An estimated 100 million Americans have medical debts. Their bills make up about half of all outstanding debt in the country.

About 20 percent of hospitals nationwide have debt-collection policies that allow them to cancel care, according to an investigation last year by KFF Health News. Many of those are nonprofits. The government does not track how often hospitals withhold care

Under federal law, hospitals are required to treat everyone who comes to the emergency room, regardless of their ability to pay. But the law — called the Emergency Medical Treatment and Labor Act — is silent on how health systems should treat patients who need other kinds of lifesaving care, like those with aggressive cancers or diabetes.

Andrew Bryant can still remember when he thought of climate change as primarily a problem of the future. When he heard or read about troubling impacts, he found himself setting them in 2080, a year that, not so coincidentally, would be a century after his own birth. The changing climate, and all the challenges it would bring, were “scary and sad,” he said recently, “but so far in the future that I’d be safe.”

That was back when things were different, in the long-ago world of 2014 or so. The Pacific Northwest, where Bryant is a clinical social worker and psychotherapist treating patients in private practice in Seattle, is a largely affluent place that was once considered a potential refuge from climate disruption

“We’re lucky to be buffered by wealth and location,” Bryant said. “We are lucky to have the opportunity to look away.”

What is missing from the stampede of policy innovation is something to tackle one of the best-known causes of high costs in the book: excessive market concentration.

The share of metropolitan areas with highly concentrated hospital markets, by the standards of antitrust enforcers at the Justice Department and the Federal Trade Commission, rose to 77 percent from 63 percent over the period.

And consolidation is continuing. Professor Gaynor counts more than 1,000 hospital system mergers since the mid-1990s, often involving dozens of hospitals. In 2002 doctors owned about three in four physician practices. By 2008 more than half were owned by hospitals.

REYHANLI, Turkey — When the wounded arrived at the Red Crescent hospital in Idlib at the start of the Syrian uprising — opponents of President Bashar al-Assad who had been shot or beaten by government troops — military police ordered the doctors to just let them die.

Ammar Martini and his colleagues refused.

“This I could not do,” said Martini, a successful surgeon from an affluent family. “I treat all people, of any origin. They are human, and I am a doctor.”

But she has to watch her step. If she crosses a painted yellow semicircle outside the clinic’s entrance, she commits a crime under a 2007 Massachusetts law.

The Supreme Court will hear arguments on Wednesday in her challenge to the law.

The Supreme Court’s 2000 decision upheld a complicated law that established 100-foot buffer zones outside all health care facilities, not just abortion clinics. Inside those larger zones, the law banned approaching others within eight feet for protest, education or counseling without their consent.

With more than 2 million Syrians already living outside their war-torn country and 1 million more expected to flee in the coming months, there is a growing protection gap. Indeed, a report (PDF) released in November by Harvard University shows that even Canada, which prides itself on being hospitable to refugees, has been systematically closing its borders to asylum seekers. Without a doubt, development-related aid is an important incentive to host countries, and providing sanctuary for vulnerable populations is just as vital, but what refugees need most is a legal status, which can be achieved only through a regional framework of protection and national asylum policies. The Bangkok Principles are a good start because they highlight the commitment among these states to develop a regional framework and national solutions to protect refugees, with the support of the international community. The U.S. must do its part and encourage the Middle East to build on these principles. Syrians deserve an organized and effective framework, and the risk of turning our backs is that Syrians, along with the Palestinians, will be wandering without a homeland. Galya Benarieh Ruffer is the founding director of the Center for Forced Migration Studies at the Buffett Center for International and Area Studies at Northwestern University and a public voices faculty fellow with the OpEd Project.  The views expressed in this article are the author's own and do not necessarily reflect Al Jazeera America's editorial policy. 180401 Join the Conversation Post a new commentLogin   c

Although the cause of Syrians fleeing their homeland today differs fundamentally from the flight of Palestinians in 1948, one crucial similarity is the harsh reception they are experiencing in neighboring countries. The tragedy of the Syrian refugee crisis is palpable in news stories and in the images of those risking their lives in rickety boats on Europe’s shores. More than one-third of Syria’s population has been displaced, and its effects are rippling across the Middle East. For months, more than 1,500 Syrians (including 250 children) have been detained in Egypt. Hundreds of adults are protesting grotesque conditions there with a hunger strike. Lebanon absorbed the most refugees but now charges toward economic collapse, while Turkey will house 1 million Syrians by the year’s end.

The surge of Syrians arriving in urban centers has brought sectarian violence, economic pressure and social tensions. As a result, these bordering countries, having already spent billions of dollars, are feeling less hospitable and are starting to close their borders to Syrians.

A group of leading biologists on Thursday called for a worldwide moratorium on use of a new genome-editing technique that would alter human DNA in a way that can be inherited.

The biologists fear that the new technique is so effective and easy to use that some physicians may push ahead before its safety can be assessed. They also want the public to understand the ethical issues surrounding the technique, which could be used to cure genetic diseases, but also to enhance qualities like beauty or intelligence. The latter is a path that many ethicists believe should never be taken.

a technique invented in 2012 makes it possible to edit the genome precisely and with much greater ease. The technique has already been used to edit the genomes of mice, rats and monkeys, and few doubt that it would work the same way in people.

Even at their most effective – and draconian – containment strategies have only slowed the spread of the respiratory disease Covid-19. With the World Health Organization finally declaring a pandemic, all eyes have turned to the prospect of a vaccine, because only a vaccine can prevent people from getting sick.

This unprecedented speed is thanks in large part to early Chinese efforts to sequence the genetic material of Sars-CoV-2, the virus that causes Covid-19. China shared that sequence in early January, allowing research groups around the world to grow the live virus and study how it invades human cells and makes people sick.

Coronaviruses have caused two other recent epidemics – severe acute respiratory syndrome (Sars) in China in 2002-04, and Middle East respiratory syndrome (Mers), which started in Saudi Arabia in 2012. In both cases, work began on vaccines that were later shelved when the outbreaks were contained. One company, Maryland-based Novavax, has now repurposed those vaccines for Sars-CoV-2, and says it has several candidates ready to enter human trials this spring. Moderna, meanwhile, built on earlier work on the Mers virus conducted at the US National Institute of Allergy and Infectious Diseases in Bethesda, Maryland.

Zhang Xinmin, an official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.

“It has a high degree of safety and is clearly effective in treatment,” Zhang told reporters on Tuesday.

Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.

Terrifying though the coronavirus may be, it can be turned back. China, South Korea, Singapore and Taiwan have demonstrated that, with furious efforts, the contagion can be brought to heel.

for the United States to repeat their successes will take extraordinary levels of coordination and money from the country’s leaders, and extraordinary levels of trust and cooperation from citizens. It will also require international partnerships in an interconnected world.

This contagion has a weakness.

The Supreme Court on Wednesday took up June Medical Services v. Russo, which considers the constitutionality of a 2014 Louisiana law requiring doctors who perform abortions to obtain admitting privileges at a hospital within 30 miles of their clinic, a credential many abortionists do not have. According to critics of the law, it threatens to shut down all but one abortion clinic in Louisiana, which sees roughly 10,000 abortions every year